Our Products marketed in the United Kingdom
CEVENFACTA® ▼ Eptacog Beta (activated)
Powder and solvent for infusion
Product Information
Click here to access the Patient Information Leaflet or Summary of Product Characteristics for CEVENFACTA®▼.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme.
By reporting side effects you can help provide more information on the safety of this medicine.
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
FIBCLOT® Human fibrinogen
Product Information
Click here to access the Patient Information Leaflet or Summary of Product Characteristics for FibCLOT®.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme.
By reporting side effects you can help provide more information on the safety of this medicine.
IQYMUNE® Human normal immunoglobulin
IQYMUNE® Human normal immunoglobulin (IVIg) solution for infusion 100 mg/mL
10% ready to use immunoglobulin
Product Information
Click here to access the Patient Information Leaflet or Summary of Product Characteristics for IQYMUNE®.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme.
By reporting side effects you can help provide more information on the safety of this medicine.
WILLFACT® Human von Willebrand factor
Product Information
Click here to access the Patient Information Leaflet or Summary of Product Characteristics for WILLFACT®.
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme.
By reporting side effects you can help provide more information on the safety of this medicine.
Job Code: NP-25/10/001 – Date of preparation: November 2025